S 658 – North Carolina
Introduced: 2019 Status: Inactive / Dead
Prescription Drug Pricing: Requires manufacturers to notify interested parties, which include State agencies that purchase prescription drugs or have specified classes of employees, of upcoming substantial price increases (defined as an increase that causes the …
S 7028 (see companion bill A 5249) – New York
Introduced: 2018 Status: Inactive / Dead
PRICE GOUGING. Establishes the crime of price gouging as a violation, authorizing district attorneys to pursue violations, and clarifying that no state of emergency need be declared by the governor for the enforcement of the …
S 712 – Massachusetts
Introduced: 2019 Status: Inactive / Dead
For legislation to promote transparency and prevent price gouging of pharmaceutical drug prices. Health Care Financing.
S 783 – Massachusetts
Introduced: 2023 Status: In Process
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
S 804 (replaced by S 771) – Massachusetts
Introduced: 2021 Status: Inactive / Dead
To promote transparency and prevent price gouging of pharmaceutical drug prices
S 919 (see companion bill A 2488) – New Jersey
Introduced: 2020 Status: Inactive / Dead
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
S.C. Code Ann. § 39-5-145. Price gouging during emergency; definitions; penalty; evidence of knowledge or intent: South Carolina Unfair Trade Practices Act – South Carolina
Status: Enacted Year Enacted: 2002
Upon a declaration of a state of emergency by the Governor, it is unlawful and a violation of this article for a person or his agent or employee to: rent or sell or offer to …
Download
S.D. Codified Laws § 58-41-44. Charges to enrollees–Fairness–Actuary’s certificate: Health Maintenance Organizations – South Dakota
Status: Enacted Year Enacted: 1974
The charges to enrollees shall not be excessive, inadequate, or unfairly discriminatory.
Download
S.D. Codified Laws § 58-41-57. Payment of unreasonably high expenses as misdemeanor: Health Maintenance Organizations – South Dakota
Status: Enacted Year Enacted: 1974
No health maintenance organization shall incur or pay for any expense of any nature which is unreasonably high in relation to the value of the service or goods provided. Violation of this section is a …
Download
SB 0963 (see companion bill HB 0887) – Tennessee
Introduced: 2019 Status: Inactive / Dead
Drugs, Prescription – As introduced, enacts the “Prescription Drug Fair Pricing Act.” – Amends TCA Title 4; Title 53; Title 56; Title 63; Title 68 and Title 71.
SB 1172 – Pennsylvania
Introduced: 2018 Status: Inactive / Dead
An Act amending the act of October 31, 2006 (P.L.1210, No.133), known as the Price Gouging Act, further providing for definitions, for price gouging prohibited and for investigation. Vetoed by Governor
SB 1196 – California
Introduced: 2020 Status: Enacted
Price gouging. Under existing law, upon the proclamation of a state of emergency, as defined, by the President of the United States or the Governor, or upon the declaration of a local emergency, as defined, …
SB 13 – Connecticut
Introduced: 2022 Status: Inactive / Dead
The bill prohibits pharmaceutical manufacturers from selling a prescription drug for a price higher than the drug’s reference price (i.e., the drug’s wholesale acquisition cost) adjusted for changes in the consumer price index for urban …
SB 1300 – Idaho
Introduced: 2022 Status: Inactive / Dead
CONSUMER PROTECTION – Amends existing law to prohibit taking advantage of a disaster or an emergency by charging exorbitant or excessive prices for temporary health care services.
SB 1308 – Virginia
Introduced: 2019 Status: Inactive / Dead
Prescription drug price gouging prohibited. Prohibits unconscionable price increases in the price of essential off-patent or generic drugs, authorizes the Secretary of Health and Human Resources to designate drugs as essential drugs, and establishes an …
SB 1328 (see companion bill HB 267) – Hawaii
Introduced: 2019 Status: Inactive / Dead
Requires that if a proposed increase in the wholesale price of certain drugs would result in a 16% or more price increase over a 2 year period, the drug manufacturer shall notify various drug insurance …